RC
Rahul Choudhary
About Rahul Choudhary
Rahul Choudhary has 14 years in corporate governance. Holds Director and Nominee roles. Currently with 3 companies, including Astemax Biotech Private Limited and Essendon Formulations Private Limited. Formerly with 4 companies, such as Astemax Biotech Private Limited and Mathis Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Astemax Biotech Private Limited
U24100HR2011PTC043480
|
Director | 21 Feb 2022 | 2011 | Active |
Essendon Formulations Private Limited
U24299HR2021PTC098258
|
Director | 06 Oct 2021 | 2021 | Active |
Atlina Lifesciences Private Limited
U51909HR2016PTC063931
|
Nominee | 04 May 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Astemax Biotech Private Limited
U24100HR2011PTC043480
|
Director | 12 Jun 2018 | 2011 | Active |
Mathis Pharma Private Limited
U24100HR2011PTC044472
|
Director | 23 Apr 2012 | 2011 | Strike Off |
Astemax Biotech Private Limited
U24100HR2011PTC043480
|
Director | 27 Aug 2020 | 2011 | Active |
Astemax Biotech Private Limited
U24100HR2011PTC043480
|
Director | 25 Jul 2011 | 2011 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Frequently Asked Questions about Rahul Choudhary
Rahul Choudhary has 14 years in corporate governance. Holds Director and Nominee roles. Currently with 3 companies, including Astemax Biotech Private Limited and Essendon Formulations Private Limited. Formerly with 4 companies, such as Astemax Biotech Private Limited and Mathis Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Rahul Choudhary is associated with 3 companies as Director and Nominee.
Rahul Choudhary has expertise in Technology, General Business.
Rahul Choudhary has 14 years in corporate governance.